Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA067270-01A1S1
Application #
2376966
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1996-07-01
Project End
2000-04-30
Budget Start
1996-07-01
Budget End
1997-04-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
University of Texas MD Anderson Cancer Center
Department
Other Basic Sciences
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030

  Publications

Andersson, Borje S; Murray, David (2002) Model studies of cyclophosphamide resistance in human myeloid leukemia. Cancer Treat Res 112:211-35
Sladek, Norman E (2002) Leukemic cell insensitivity to cyclophosphamide and other oxazaphosphorines mediated by aldehyde dehydrogenase(s). Cancer Treat Res 112:161-75
Murray, D; Vallee-Lucic, Loretta; Rosenberg, Elizabeth et al. (2002) Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide. Anticancer Res 22:21-6
Murray, David (2002) DNA repair in resistance to bifunctional alkylating and platinating agents. Cancer Treat Res 112:129-60
Munker, R; Zhao, S; Jiang, S et al. (1998) Further characterization of cyclophosphamide resistance: expression of CD95 and of bcl-2 in a CML cell line. Leuk Res 22:1073-7